![Colin Smith Mackay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Smith Mackay
Director Ejecutivo en Symbiosis Pharmaceutical Services Ltd. .
Perfil
Colin Smith Mackay has held positions as Chief Executive Officer at Symbiosis Pharmaceutical Services Ltd.
and Director at Symbiosis Holdings (Scotland) Ltd.
Cargos activos de Colin Smith Mackay
Empresas | Cargo | Inicio |
---|---|---|
Symbiosis Pharmaceutical Services Ltd.
![]() Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Director Ejecutivo | - |
Symbiosis Holdings (Scotland) Ltd.
![]() Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Director/Miembro de la Junta | 04/03/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Symbiosis Pharmaceutical Services Ltd.
![]() Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Health Technology |
Symbiosis Holdings (Scotland) Ltd.
![]() Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Finance |
- Bolsa de valores
- Insiders
- Colin Smith Mackay